A double-blind, placebo-controlled phase Ila study investigating CYT003-QbG10 as a novel immunotherapy in patients suffering from house dust mite allergy - Kuendig, T; Pichler, C; Scherer, K; Bircher, A; Mueller, P; Ulrich, M; Bachmann, M; Renner, W; Senti, G (ALLERGY, 2007)